[WEBINAR] Autoimmune Antibodies: A Missing Piece in M.E., POTS, and Long COVID?
Join us for the first in a series of webinars highlighting the groundbreaking testing offered by CellTrend Laboratory in Germany. Emerging research is uncovering the role of a novel class of biomarkers: autoantibodies, which are antibodies that mistakenly target the body’s own receptors in complex neuroimmune and autonomic disorders such as Myalgic Encephalomyelitis (M.E.), Postural Orthostatic Tachycardia Syndrome (POTS), Small
Free